Nitric Oxide Scavenging, HBOC Vasoconstriction & Tissue Oxygenation
Why oxygen-carrying capacity alone does not define effective oxygen delivery.
1. The Study
PubMedPMID 25810253
DOI10.1073/pnas.1502285112
2. Key Finding
The study examined mice in which hemoglobin βCys93 was replaced by alanine. Hemoglobin could still carry oxygen, but hypoxic vasodilation, peripheral blood flow and tissue oxygenation were impaired.
3. Why This Is Important
Hemoglobin is part of a larger oxygen-delivery system. The physiological endpoint is not simply how much O₂ is bound to hemoglobin, but whether oxygen reaches tissue through an adequately regulated microcirculation.
This connects three functions that should be evaluated together: oxygen carriage → vascular response → tissue oxygenation.
4. Relevance to HBOC and BHOC
Cell-free hemoglobin interacts with nitric oxide differently from hemoglobin enclosed inside red blood cells. In the HBOC literature, nitric oxide scavenging is a major mechanism associated with vasoconstriction, increased vascular resistance and altered perfusion.
For BHOC development, the practical question is therefore not only “How much oxygen can the carrier transport?” but also “What happens to vascular tone, microcirculatory flow and oxygen unloading after administration?”
Comparative evidence from a different extracellular-hemoglobin architecture reinforces the need for product-specific vascular testing. In a 2012 preclinical study, Tsai and colleagues evaluated the natural extracellular hemoglobin M101 using arterial-pressure and microcirculatory measurements together with NO and CO reaction kinetics. The investigators reported no detectable microvascular vasoconstriction in the tested hamster model and different NO/CO binding kinetics from human hemoglobin. This finding is model- and product-specific and should not be generalized to BHOC or to the HBOC class as a whole.
5. Supporting References
1998 Nobel foundation: Nitric Oxide & Vascular Physiology →